Asenapine: novel antipsychotic for treatment of bipolar I disorder

    loading  Checking for direct PDF access through Ovid

Abstract

Asenapine is a new antipsychotic agent with activity for multiple receptors. It is administered sublingually for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. In this Drug profile the authors review the pharmacodynamic and pharmacokinetic properties of asenapine, and discuss its efficacy in bipolar I disorder and its likely positioning in clinical practice.

Related Topics

    loading  Loading Related Articles